STOCK TITAN

New investor at Jewett-Cameron (JCTC) gains board seat and 2028 share options

(High)
(Neutral)
Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

Kotarba Partners Fund I, LP and related parties reported a significant stake in Jewett-Cameron Trading Company Ltd. They are deemed to beneficially own 738,534 common shares, representing approximately 20.98% of the 3,520,113 shares outstanding as of July 14, 2026. The position comes from a Purchase and Sale Agreement with The Oregon Community Foundation covering: 176,006 shares the fund must buy at $1.85 per share, another 176,006 shares it may buy at $1.85, and up to 386,522 shares it may buy at 85% of the 30‑day volume weighted average price with a floor of $1.85 and cap of $4.00. The first 352,012 shares require $651,222.20 of working capital; the remaining 386,522 shares would cost between $715,065.70 and $1,546,088.00 in total. The option can be exercised in parts through March 31, 2028. Scott Kotarba was appointed to the company’s board effective August 10, 2026, and the reporting group states it will continue to review its investment and may buy more, sell, or exercise its option depending on future conditions.

Positive

  • None.

Negative

  • None.

Filing Explained

The reported 20.98% stake is presently a contractual, unclosed acquisition; the seller retains voting and sale rights until each purchase closes.

Schedule 13D reports ownership above 5%; here, the reporting group reports deemed beneficial ownership of 738,534 common shares, or 20.98%, through purchase rights rather than completed purchases.

Although the filing describes the event as an acquisition of beneficial ownership, it states that no consideration was paid and no closing had occurred as of the statement date. Until each applicable closing, the seller retains record and beneficial ownership plus voting and dispositive power over shares not yet purchased.

The reported 738,534-share position assumes full exercise of rights exercisable within 60 days for reporting purposes; the amounts attributed to the three reporting persons are the same shares, not an additional combined position.

The initial closing must occur by September 30, 2026, unless extended; the optional rights remain exercisable through March 31, 2028, with each applicable closing due within ten business days after notice.

Beneficial ownership 738,534 shares Shares Jewett-Cameron common stock deemed beneficially owned by the reporting persons
Ownership percentage 20.98% Portion of Jewett-Cameron’s 3,520,113 shares outstanding as of July 14, 2026
Shares outstanding 3,520,113 shares Jewett-Cameron common shares outstanding as of July 14, 2026
Fixed share tranches 176,006 + 176,006 shares One tranche obligated and one optional, each at $1.85 per share
Formula-priced shares 386,522 shares Optional purchases at 85% of 30‑day VWAP, price between $1.85 and $4.00
Initial capital outlay $651,222.20 Working capital used for first 352,012 shares
Min/Max cost for remaining shares $715,065.70–$1,546,088.00 Aggregate price range for 386,522 shares under option formula
Option exercise deadline March 31, 2028 Last date to exercise rights for optional share purchases
beneficial ownership financial
"The aggregate number and percentage of Shares beneficially owned by each Reporting Person"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Purchase and Sale Agreement financial
"pursuant to the Purchase and Sale Agreement, dated as of August 6, 2026"
A purchase and sale agreement is a legally binding contract that spells out exactly what is being bought or sold, the price, who must do what, the timeline, and any conditions that must be met before the deal closes — like a detailed recipe and checklist for a transaction. Investors care because this document determines when ownership or assets change hands, what risks or obligations remain, and which conditions (financing, approvals, inspections) could delay, alter, or void the deal and therefore affect a company’s value and stock price.
volume weighted average price financial
"at a price per Share equal to 85% of the volume weighted average price of the Shares"
The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.
Schedule 13D regulatory
"is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g)"
A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.
dispositive power financial
"Sole Dispositive Power 0.00 Shared Dispositive Power 738,534.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
pecuniary interest financial
"disclaims beneficial ownership of the Shares reported herein except to the extent of its or his pecuniary interest"

FAQ

What stake in Jewett-Cameron (JCTC) does Kotarba Partners report on this Schedule 13D?

The reporting group is deemed to beneficially own 738,534 Jewett-Cameron shares, or approximately 20.98% of the company’s 3,520,113 shares outstanding as of July 14, 2026, based on rights under a Purchase and Sale Agreement.

How is the Kotarba Partners stake in JCTC structured and priced?

The stake covers 176,006 shares they must buy at $1.85, another 176,006 shares they may buy at $1.85, and up to 386,522 shares at 85% of 30‑day VWAP, with a price floor of $1.85 and cap of $4.00 per share.

How much capital could Kotarba Partners deploy to acquire JCTC shares under the agreement?

They used $651,222.20 of working capital for the first 352,012 shares. The remaining 386,522 shares would cost between $715,065.70 and $1,546,088.00 in total, depending on future market-based pricing within the agreement’s formula.

Over what period can Kotarba Partners exercise its option to buy additional JCTC shares?

Kotarba Partners Fund I, LP may exercise its option rights for up to 386,522 shares at formula pricing any time on or before March 31, 2028, with each closing occurring within ten business days after giving written notice to the seller.

What governance role did Scott Kotarba gain at Jewett-Cameron (JCTC)?

Scott Kotarba was appointed to Jewett-Cameron’s board of directors effective August 10, 2026. As a board member, he participates in the company’s management and policies and may take positions on matters presented to the board.

Who is selling the JCTC shares subject to Kotarba Partners’ purchase rights?

The shares are being sold by The Oregon Community Foundation under a Purchase and Sale Agreement dated August 6, 2026. Until each closing, the foundation retains record and beneficial ownership, including voting and dispositive power, over the shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





47733C207

(CUSIP Number)
Scott Kotarba
1827 Broken Bend Drive,
Westlake, TX, 76262
415-608-3025

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
08/06/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Kotarba Partners Fund I, LP
Signature:Scott Kotarba
Name/Title:By: Scott Kotarba, Managing Member of Kotarba Partners & Co, LLC, General Partner of Kotarba Partners Fund I, LP
Date:08/17/2026
Kotarba Partners & Co, LLC
Signature:Scott Kotarba
Name/Title:Scott Kotarba, Managing Member
Date:08/17/2026
Scott Kotarba
Signature:Scott Kotarba
Name/Title:Scott Kotarba
Date:08/17/2026